Variation within the gene for the proinflammatory cytokine interleukin (IL)-18 has been associated with inter-individual differences in levels of free protein and disease risk. We investigated the frequency of function-associated IL18 gene haplotypes in an extensive sample (n ¼ 2357) of African populations from across the continent. A previously identified five tagging SNP (single-nucleotide polymorphism) haplotype (here designated hGTATA), known to be associated with lower levels of IL-18, was observed at a frequency of 27% in a British population of recent European ancestry, but was found at low frequency (o8%) or completely absent in African populations. Potentially protective variants may, as a consequence, be found at low frequency in African individuals and may confer a difference in disease risk.
INTRODUCTION

Interleukin (IL)-18 is a pleiotropic cytokine involved in both innate
and adaptive immune responses. 1,2 Variation in the IL18 gene has been shown to influence circulating levels of IL-18, 3-6 is associated with risk for various inflammatory diseases including cardiovascular disease (CVD), [7] [8] [9] and affects production of IL-18 by monocytes. 10, 11 Though the distribution of genetic variation in IL18 in populations of recent European origin has been examined, little is known about populations more globally. We have therefore investigated the distribution across Africa by determining the frequency of potentially informative haplotypes and compared the results with populations from neighbouring regions and the UK.
MATERIALS AND METHODS Subjects
DNA samples (buccal swabs) from males over 18 years old unrelated at the paternal grandfather level (n ¼ 2572) were selected from the Centre for Genetic Anthropology sample collection to represent a wide selection of ethnic groups distributed across and close to Africa (Table 1) . Individual populations were additionally amalgamated into broader geographical groups to assess regional variation. Samples from the second Northwick Park Hospital Heart Study cohort (NPHSII, n ¼ 2696), 12 which consists of individuals of European biogeographic ancestry aged 51-60 years from nine general medical practices across the UK, were used to represent a population of recent north-west European/UK ancestry.
Genotyping
All samples were typed for five IL18 tagging single-nucleotide polymorphisms (tSNPs). 13 TaqMAN probes were designed for all five tSNPs ( À9731 G4T (rs1946519); À5848 T4C (rs2043055); þ 4860 A4C (rs549908); þ 8855 T4A (rs360729); þ 11015 A4C (rs3882891)) and assayed on an ABI Prism 7000 (Life Technologies Corporation, Carlsbad, CA, USA) sequence detection system. All per-SNP genotyping rates were 495%. A subset of samples, homozygous at all of the above positions, were genotyped for three further SNPs ( À8949 C4T (rs360717); þ 11640 A4G (rs5744292); þ 11990 T4C (rs4937100)). Genotyping of À8949 C4T and þ 11640 A4G was carried out by K Biosciences (Hoddesdon, UK). Genotyping of þ 11990 T4C was carried out using dideoxy sequencing as previously described.
Statistical analysis
Data handling and plotting, principle co-ordinate analysis (PCO), and unweighted pair group method with arithmetic mean (UPGMA) clustering analysis were performed using R. 14 Arlequin v3.5.1.2 15 was used to: test for departures from Hardy-Weinberg equilibrium; estimate gene diversity (h), assess pairwise differences in SNP and haplotype frequencies; and perform Mantel and AMOVA tests. PHASE v2.1 16, 17 was used to estimate haplotype frequencies and impute missing data. 95% Confidence intervals (CIs) and significant differences for h were assessed using bootstrapping of populations within groups and permutation among groups, respectively (number of iterations ¼ 10 000).
RESULTS
Single SNP analysis
Single SNP frequencies are shown in Supplementary Figure 1 . Substantial variation in allele frequencies was observed across all populations with large ranges seen in minor allele frequency. Significant among-population variation was observed for all SNPs (Po0.001) as assessed by a frequency-based AMOVA framework. For three of the five SNPs, gene diversity (the probability of sampling two different alleles) was higher in European and North African populations (NSAH) than in sub-Saharan (SSAH) populations (mean Table 1 ).
Haplotype frequency analysis
In total, 19 haplotypes were inferred from the five SNPs, with 9 haplotypes found at a frequency greater than 2% in at least one population (Figure 1 and Supplementary Table 2) . hGCATA was the modal haplotype in all populations (frequency range 29.0-56.6%), and only two other haplotypes were identified in every population (hTTATC and hTTCAC, frequency ranges of 6.7-28.9% and 6.6-36.8%, respectively). Haplotype diversity was significantly (Po0.01) higher in NSAH (h ¼ 0.733, 95% CI ¼ 0.718-0.747) than SSAH (h ¼ 0.703, 95% CI ¼ 0.687-0.718, Supplementary Table 1) , although the number of haplotypes were fewer. The higher diversity in NSAH is most likely due to the dominance of GCATA in SSAH (around 50% in many SSAH populations) and the resultant paucity of equally frequent haplotypes. AMOVA analysis indicated that there is significant among-population variation in haplotype frequency (FST ¼ 2.2%, Po0.001). A haplotype associated with lower IL-18 protein levels, hGTATA, was found at a frequency of 26.6% in the UK populations, but was absent or at low frequency in sub-Saharan Africa (median frequency of hGTATA was 0.0% across sub-Saharan populations).
Geographic distribution of IL18 variation
PCO of the population pairwise haplotype-based F ST matrix showed the African populations forming a wide scatter while the European populations formed a more distinct cluster (Figure 2) . UPGMA clustering analysis with K ¼ 3 identified clear population clusters. One (Cluster_1) consisted of all European, North African and Anatolian Turkish groups, and one (Cluster_2) contained both ARB populations and all SSAH populations except SSD and EAN, which together made up the last cluster (Cluster_3) (see Supplementary Table 2 for haplotype frequencies within each cluster). The final cluster appears to be the result of a higher than average hGCATC frequency compared to other SSAH populations. Interestingly, the Anuak of Ethiopia (EAN) are believed to descend from a larger group from South Sudan (SSD). A Mantel test showed a significant (R 2 ¼ 0.197, Po0.001) correlation between pairwise genetic and geographic (great circle) distances.
Relationship to published haplotypes An IL18 haplotype (htirGCAGT) composed of five SNP alleles, of which two ( À9731 G and þ 4860 A) are shared with hGTATA (Supplementary Table 3 ), has been shown to be associated with lower IL-18 protein 8 and mRNA levels 11 along with decreased CVD risk. 8 Given both htirGCAGT and hGTATA have been associated with lower levels of IL-18, we investigated whether the two haplotypes might exist on similar or the same genomic sequences. The three uncharacterised SNPs from htirGCAGT were genotyped in a set (n ¼ 18) of hGTATA homozygotes from the UK and a subset (n ¼ 87) of African samples, homozygous for various haplotypes. All UK samples were also homozygous for htirGCAGT, while in the African samples, six of the eight chromosomes known to carry hGTATA carried htirGCAGT (Supplementary Table 4 ). The two remaining chromosomes carried htirGCAAT and htirGCAGC. None of the African samples homozygous for non-hGTATA haplotypes carried htirGCAGT.
DISCUSSION
The results from this study indicate that, although all studied SNP alleles were found at appreciable frequencies in all populations, the distribution of IL18 genetic variation differs greatly between Africa and Europe. The most striking example of this difference is the complete absence of the second most common European haplotype, hGTATA, which is known to be associated with lower circulating IL-18 levels, in the vast majority of the sub-Saharan samples studied here. Although a full exploration of the possible evolutionary mechanisms of this observation are beyond the scope this report, it is interesting to note that studies of other interleukin genes such as IL-10 have suggested that natural selection may be acting on proinflammatory haplotypes within the peoples of sub-Saharan Africa and Caucasians. 18 In addition, contrary to our expectations, we observed significantly higher gene diversity indices in the European populations when compared with the African populations at three tSNPs and at the haplotype level. It is likely that this is a result of the tSNPs used here being ascertained in European samples, and that with analysis of full resequencing data, we would observe higher genetic diversity in the African populations. Soon-to-be abundant data for IL18 derived from large whole-exome sequencing projects will be particularly useful for understanding patterns of European and African IL18 diversity.
We also found evidence that hGTATA is tagging the same genewide sequence as htirGCAGT, which has previously been found to be associated with lower levels of both IL-18 and CVD risk in European individuals, 8 which strongly suggests that the same potentially functional polymorphism(s) could be found on the background of both haplotypes. Although there was less correlation between the two haplotypes in African individuals, htirGCAGT was found only on chromosomes carrying hGTATA. Resequencing of this genomic region in association studies recording IL-18 levels in individuals homozygous for htirGCAGT/hGTATA in a search for causative polymorphisms could prove rewarding. IL-18 is an important inflammatory regulator, and as well as CVD has also been associated with autoimmunity, 19 appetite regulation/energy homeostasis 20, 21 and protection from Plasmodium falciparum malaria. [22] [23] [24] As such, it is likely that functional genetic variation within IL18 will influence disease susceptibility. 7 Figure 1 Common haplotype frequencies by population. See Table 1 for population codes. Table 1 for population codes.
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We hope this relatively simple survey of genetic variation will motivate genotype:phenotype studies involving IL-18 that will focus specifically on cohorts of recent African ancestry (such studies are currently largely absent from the literature). African Americans, for example, are known to have high rates of CVD and our results suggest that such studies may be very beneficial for this group.
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